Stocks linked to vaccine developers such as Moderna, Pfizer and Novavax tanked in the leadup to market close Thursday, ...
The Cambridge-based company’s latest COVID shot was approved three weeks earlier than last year, according to a statement ...
Leerink Partners analyst Mani Foroohar assigned a Sell rating on Moderna (MRNA – Research Report) on November 7 and set a price target of ...
Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...
Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar with the matter.
Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...
Coegi used more than 500 million impressions and paid social optimized with attention and emotion metrics to drive 24% of ...
Moderna reported earnings that exceeded expectations due to effective cost management but still has challenges related to its ...
Barchart on MSN2d
Moderna Stock Outlook: Is Wall Street Bullish or Bearish?Headquartered in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a biotechnology company specializing in messenger RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback